Month: August 2025

Early-Onset Neonatal Sepsis (EONNS)

eonns vs lonns

Early-Onset Neonatal Sepsis refers to systemic infection occurring within the first 72 hours of life (some definitions extend up to 7 days in term neonates). It is a medical emergency characterized by a rapid progression from nonspecific signs to septic shock, multi-organ dysfunction, and death if not promptly treated.

The pathogenesis is primarily linked to vertical transmission of microorganisms from mother to infant, either intrauterine (transplacental hematogenous spread) or intrapartum (ascending infection from the genital tract during labor or delivery). Infection often develops after rupture of membranes, especially when prolonged (>18 hours), or in the setting of maternal fever, chorioamnionitis, or Group B Streptococcus (GBS) colonization.

Globally, EONNS remains a significant contributor to neonatal morbidity and mortality, particularly in low- and middle-income countries, where rates are higher due to limited access to intrapartum prophylaxis, delays in recognition, and suboptimal infection control during delivery. Mortality is highest in very low birth weight (VLBW) and preterm infants, where the immature immune system and compromised skin/mucosal barriers amplify vulnerability.

The microbiological profile varies by region. In high-income settings, GBS and Escherichia coli dominate, whereas in many developing countries, Gram-negative bacilli such as Klebsiella pneumoniae are increasingly prevalent. Importantly, EONNS often presents with respiratory distress, apnea, temperature instability, and lethargy, sometimes within minutes of birth.

Prompt diagnosis relies on high clinical suspicion, early blood cultures, and sepsis screening, followed by empiric antibiotic therapy (usually ampicillin plus gentamicin) while awaiting culture confirmation. Prevention strategies — especially maternal GBS screening and intrapartum antibiotic prophylaxis — have markedly reduced incidence in settings where implemented.

Late-Onset Neonatal Sepsis (LONNS)

Late-Onset Neonatal Sepsis refers to systemic infection occurring after 72 hours of life (or after 7 days in some term-based definitions) up to 28 days of age in term infants, and up to 44 weeks corrected gestational age in preterm infants. Unlike EONNS, its etiology is dominated by horizontal transmission of pathogens, often acquired in the hospital environment (nosocomial) or from community contacts after discharge.

LONNS frequently affects preterm and critically ill neonates in the neonatal intensive care unit (NICU), where prolonged hospitalization, mechanical ventilation, invasive procedures, and parenteral nutrition predispose to infection. Biofilm-forming organisms such as coagulase-negative staphylococci (CONS) exploit indwelling central venous catheters, while Gram-negative bacilli and fungi such as Candida spp. cause severe systemic illness, especially in extremely low birth weight (ELBW) infants.

Clinically, LONNS may have a more insidious onset than EONNS, often manifesting as apnea/bradycardia spells, feeding intolerance, abdominal distension, or subtle changes in behavior or perfusion. However, fulminant septic shock can occur, particularly in S. aureus, Klebsiella, or Pseudomonas infections. Meningitis is proportionally more common in LONNS due to delayed recognition and sustained bacteremia.

The microbial spectrum varies with hospital ecology, antibiotic use patterns, and infection control practices. In resource-limited settings, multidrug-resistant Gram-negative pathogens are a major concern, complicating empiric therapy. Common empiric regimens include vancomycin plus an aminoglycoside or ceftazidime/meropenem, tailored to local antibiograms.

Prevention of LONNS hinges on rigorous infection control measures: meticulous hand hygiene, bundle-based catheter care, minimizing unnecessary invasive devices, strict aseptic preparation of parenteral nutrition, and antimicrobial stewardship. While mortality in term infants is lower than in EONNS, LONNS remains a major cause of prolonged NICU stay, chronic lung disease, neurodevelopmental impairment, and death in preterm survivors.

Comparison Table – EONNS vs LONNS

Notes on Early & Late Onset Neonatal Sepsis

1. Definition

• Neonatal sepsis: Clinical syndrome of systemic illness accompanied by bacteremia in the first 28 days of life.

• EONNS: ≤72 hours (some guidelines use ≤7 days in term).

• LONNS: >72 hours (or >7 days in term) up to 28 days (in preterm, up to 44 weeks corrected age).

2. Pathophysiology

• EONNS:

  • Infection is acquired intrauterine (transplacental hematogenous spread) or intrapartum (ascending infection from vagina after rupture of membranes).

  • Pathogens invade amniotic fluid → fetus aspirates/swallow infected fluid → hematogenous spread.

• LONNS:

  • Mainly nosocomial or community-acquired after birth.

  • Immature neonatal immune system + invasive devices = high susceptibility.

  • Biofilm-forming organisms (e.g., CONS) on catheters are key in pathogenesis.

3. Risk Factors

EONNS:

• PROM >18 hrs

• Maternal fever during labor (>38°C)

• Chorioamnionitis

• GBS colonization without prophylaxis

• Preterm (<37 wks)

• Meconium-stained liquor

• Low Apgar (<6 at 5 min)

LONNS:

• Prolonged NICU stay

• Invasive devices: ET tubes, central lines

• Surgery, necrotizing enterocolitis

• Poor infection control

• Broad-spectrum antibiotic exposure

4. Microbiology

• EONNS (classic teaching):

  • GBS (Streptococcus agalactiae) – most common in term

  • E. coli – more common in preterm, high mortality

  • Listeria monocytogenes – rare but important in unpasteurized dairy exposure

  • Others: Klebsiella, Enterococcus

• LONNS:

  • CONS – esp. in VLBW with catheters

  • S. aureus (MRSA possible)

  • Gram-negatives: Klebsiella, Pseudomonas, Acinetobacter

  • Candida albicans / C. parapsilosis

5. Clinical Features

• Non-specific signs — must have high suspicion.

• EONNS often presents with:

  • Respiratory distress (pneumonia common)

  • Apnea, cyanosis

  • Poor feeding, lethargy

  • Hypotension, poor perfusion

  • Seizures

• LONNS:

  • Feeding intolerance, abdominal distension

  • Apnea/bradycardia spells

  • Temperature instability

  • Signs of meningitis or NEC

6. Investigations

• Blood culture (gold standard)

• CBC: leukopenia/leukocytosis, thrombocytopenia

• CRP, procalcitonin (serial trends helpful)

• CSF analysis & culture (unless unstable)

• Chest X-ray if respiratory distress

• In LONNS: line tip cultures, urine cultures

7. Management

Empirical therapy:

• EONNS: Ampicillin + Gentamicin
  (Cefotaxime can replace gentamicin if meningitis suspected & renal issues, but avoid routine use due to resistance)

• LONNS: Vancomycin + Aminoglycoside / Antipseudomonal β-lactam
  (Meropenem in multi-drug resistant GNB suspicion; guided by antibiogram)

Supportive care:

• Maintain oxygenation & perfusion

• Correct hypoglycemia

• Treat coagulopathy

• Restrict fluid in shock

8. Prognosis

• EONNS mortality: 5–50% (higher in preterm, GNB infections)

• LONNS: Mortality lower in term, but significant in VLBW; survivors risk bronchopulmonary dysplasia, neurodevelopmental delay.

9. Prevention

• EONNS: Maternal GBS screening (35–37 weeks), intrapartum antibiotics, clean delivery, timely rupture-to-delivery interval.

• LONNS: Hand hygiene, equipment sterilization, catheter bundles, antimicrobial stewardship.

Introduction

Severe acute malnutrition (SAM) complicates fluid and electrolyte balance, necessitating a specialized rehydration solution. ReSoMal—short for Rehydration Solution for Malnutrition—has lower sodium and higher potassium, plus added minerals like magnesium, zinc, and copper, making it safer for rehydration in SAM cases. It must be administered under medical supervision in therapeutic centers and is not for general use or for children with cholera.

Composition of WHO low osmolarity ORS

WHO low osmolarity ORS

Step-by-Step Guide: Preparing ReSoMal from Regular WHO ORS

Ingredients Needed (per 2 liters):

• Boiled & cooled water: 2 liters

• 1 packet of WHO low-osmolar ORS (approx. 1-liter packet)

• Sucrose (table sugar): 50 g

• Concentrated electrolyte/mineral solution: 40 ml (optional; else use potassium chloride stock)

  
  

Preparation Instructions:

1. Mix the Water & ORS Packet
   Dissolve one WHO low-osmolar ORS packet in ~2 liters of clean, cooled water.

2. Add Sugar
   Stir in 50 g of sucrose (about 2 heaped tablespoons) to increase energy and glucose content.

3. Add Mineral Solution (if available)

   • Ideally, add 40 ml of electrolyte/mineral solution—it contains potassium, magnesium, zinc, copper, and other trace minerals.

   • If unavailable, substitute with 45 ml of potassium chloride (KCl) stock—prepared by dissolving 100 g KCl in 1 liter of water.

4. Administer with Caution

   • ReSoMal contains approximately 45 mmol sodium, 40 mmol potassium, and 3 mmol magnesium per liter.

   • Follow medical protocols: typical administration is around 5–10 ml per kg per hour, depending on the child’s condition.

   • Monitor closely for signs of overhydration—rapid weight gain, elevated respiratory or pulse rates, or peripheral edema—and pause treatment if they appear.

     
     

Why not use regular ORS?

• Standard ORS has higher sodium and insufficient potassium for SAM, potentially risking fluid overload and undercorrected hypokalemia.

• ReSoMal is tailored to reduce these risks—but it may still cause hyponatremia, so careful monitoring is essential.

• It’s contraindicated in cases of cholera or profuse watery diarrhea, where standard WHO ORS is recommended instead.

  
  

Composition of ReSoMal (WHO formulation for severe malnutrition)

WHO recommended ReSoMal

Summary Table

Summary and Conclusion

ReSoMal is a life-saving adaptation of ORS for malnourished children—but it’s delicate medicine. Always follow WHO protocols and local medical guidelines, and never administer without proper training and monitoring.

Erbs palsy possible MCQ and answer explained

The image provided shows a newborn child with a characteristic position of the right upper limb. 

Important Point for Diagnosis of Renal pathologies

Cross section of kidney